D. Pardi

发表

A questionnaire for the assessment of biliary symptoms

A. Zinsmeister, W. Harmsen, C. Schleck, 2003, American Journal of Gastroenterology.

Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease

Sophie J. Weiss, R. Knight, Antonio Gonzalez, 2017, Microbiome.

Paraneoplastic dysmotility: loss of interstitial cells of Cajal

Steven M. Miller, L. Burgart, G. Farrugia, 2002, American Journal of Gastroenterology.

Prevalence and Impact of Musculoskeletal Injury Among Endoscopists: A Controlled Pilot Study

M. Crowell, J. DiBaise, D. Pardi, 2009, Journal of clinical gastroenterology.

Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

A. Zinsmeister, W. Harmsen, W. Sandborn, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency

D. Pardi, S. Khanna, P. Tosh, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Should the National GI Fellowship Matching Program Be Restored?

D. Pardi, 2004, American Journal of Gastroenterology.

Clinical management of pouchitis.

W. Sandborn, D. Pardi, 2004, Gastroenterology.

Microscopic colitis.

D. Pardi, 2003, Mayo Clinic proceedings.

Review of the Microscopic Colitides

D. Pardi, E. Yen, 2011, Current gastroenterology reports.

Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group.

D. Schwartz, U. Navaneethan, W. Sandborn, 2019, Gastrointestinal endoscopy.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Antonio Ramos, T. V. Van Schooneveld, D. Gerding, 2015, JAMA.

Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection

Robin Patel, D. Pardi, S. Khanna, 2021, Therapeutic advances in gastroenterology.

Clinical Features and Treatment Responses in Pediatric Lymphocytic and Collagenous Colitis

T. Smyrk, D. Pardi, J. Tung, 2013, Journal of pediatric gastroenterology and nutrition.

Colonic ulcers accompanying collagenous colitis: implication of nonsteroidal anti-inflammatory drugs

S. Kakar, L. Burgart, D. Pardi, 2003, American Journal of Gastroenterology.

Diagnosis and Management of Microscopic Colitis

D. Pardi, 2017, The American Journal of Gastroenterology.

Review article: microscopic colitis – lymphocytic, collagenous and ‘mast cell’ colitis

D. Pardi, E. Yen, 2011, Alimentary pharmacology & therapeutics.

Microscopic colitis: an update.

D. Pardi, 2004, Inflammatory bowel diseases.

Microscopic colitis.

D. Pardi, C. Kelly, 2011, Gastroenterology.

Review article: drug‐induced microscopic colitis – proposal for a scoring system and review of the literature

D. Pardi, L. Beaugerie, 2005, Alimentary pharmacology & therapeutics.

Microscopic colitis: a review

T. Smyrk, W. Sandborn, W. Tremaine, 2002, American Journal of Gastroenterology.

Microscopic colitis: a review

T. Smyrk, W. Sandborn, W. Tremaine, 2002 .

Meta‐analysis: serological markers and the risk of acute and chronic pouchitis

Siddharth Singh, E. Loftus, D. Pardi, 2013, Alimentary pharmacology & therapeutics.

Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Siddharth Singh, E. Loftus, D. Pardi, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Microscopic colitis

Kristin E. Burke, S. Ng, J. Ludvigsson, 2021, Nature Reviews Disease Primers.

Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection

M. Grover, D. Pardi, S. Khanna, 2021, Journal of clinical gastroenterology.

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Siddharth Singh, D. Pardi, S. Holubar, 2019, The Cochrane database of systematic reviews.

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Siddharth Singh, D. Pardi, S. Holubar, 2019, The Cochrane database of systematic reviews.

Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy.

L. M. Wong Kee Song, J. Fletcher, W. Harmsen, 2016, Gastrointestinal endoscopy.

Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium.

M. Silverberg, W. Bemelman, O. Faiz, 2022, The lancet. Gastroenterology & hepatology.

Optimization of a Scoring System to Predict Microscopic Colitis in a Cohort of Patients With Chronic Diarrhea

T. Cotter, T. Smyrk, D. Pardi, 2016, Journal of clinical gastroenterology.

Appendectomy Is Not Associated With Adverse Outcomes in Clostridium difficile Infection: A Population-Based Study

L. Baddour, J. DiBaise, D. Pardi, 2013, The American Journal of Gastroenterology.

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

W. Sandborn, D. Pardi, R. Cima, 2010, The Cochrane database of systematic reviews.

Early measles virus infection is associated with the development of inflammatory bowel disease

L. Melton, A. Zinsmeister, W. Harmsen, 2000, American Journal of Gastroenterology.

Pseudomembranous Colitis Secondary to Klebsiella oxytoca

D. Pardi, K. Schroeder, S. Sweetser, 2009, The American Journal of Gastroenterology.

Autoimmune Enteropathy: A Review and Update of Clinical Management

J. Murray, D. Pardi, N. Gentile, 2012, Current Gastroenterology Reports.

Practical Approach to Microscopic Colitis and Inflammatory Bowel Disease INFLAMMATORY BOWEL DISEASE: A PRACTICAL APPROACH, SERIES #15

D. Pardi, S. Katz, N. Fajardo, 2005 .

Microscopic Colitis and other Miscellaneous Inflammatory and Structural Disorders of the Colon

D. Pardi, E. Yen, 2015 .

Adult autoimmune enteropathy: Mayo Clinic Rochester experience.

J. Murray, D. Pardi, S. Abraham, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The Efficacy and Tolerability of AST-120 (Spherical Carbon Adsorbent) in Active Pouchitis

D. Pardi, P. Kammer, B. Shen, 2009, The American Journal of Gastroenterology.

Microscopic Colitis and Risk of Colon Adenomas: A Multicenter Retrospective Cohort Study.

D. Pardi, S. Khanna, A. Kamboj, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review.

D. Pardi, S. Khanna, P. Tosh, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Microscopic colitis: Etiopathology, diagnosis, and rational management

Toshiro Sato, O. Nielsen, D. Pardi, 2022, eLife.

Tu1381 Genome-Wide Association Identifies Multiple Collagenous Colitis Susceptibility Loci

Judy H. Cho, Ke Hao, Zhongyang Zhang, 2014 .

The surgical management of inflammatory bowel disease.

W. Koltun, D. Hahnloser, D. Pardi, 2017, Current problems in surgery.

M. Camilleri, D. Burton, D. Pardi, 2001 .

M. Camilleri, D. Burton, D. Pardi, 2001, American Journal of Gastroenterology.

Paraneoplastic dysmotility: loss of interstitial cells of Cajal.

Steven M. Miller, L. Burgart, G. Farrugia, 2002 .

Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.

Samir A. Shah, M. Silverberg, S. Vermeire, 2021, The lancet. Gastroenterology & hepatology.

Recurrent Clostridium difficile infection: an immunodeficiency state?

D. Pardi, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical guidelines for the management of pouchitis

G. D'Haens, P. Gionchetti, D. Pardi, 2009, Inflammatory bowel diseases.

Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study

T. Cotter, T. Smyrk, W. Sandborn, 2016, Gut.

Comparative Efficacy of Pharmacological Interventions in Preventing Relapse of Crohn’s Disease after Surgery: A Systematic Review and Network Meta-analysis

M. Murad, Siddharth Singh, E. Loftus, 2014 .

Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile From a Population-Based Study

W. Harmsen, D. Pardi, S. Khanna, 2022, The American journal of gastroenterology.

Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience

K. Papadakis, W. Harmsen, E. Loftus, 2021, Crohn's & colitis 360.

Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity

A. Zinsmeister, W. Sandborn, E. Loftus, 2011, Inflammatory bowel diseases.

Gastro 2013 APDW/WCOG Shanghai Working Party Report: Chronic diarrhea: Definition, classification, diagnosis

R. Spiller, G. Krejs, D. Pardi, 2014, Journal of gastroenterology and hepatology.

Clostridium difficile Infection in the Emergency Department

D. Pardi, S. Khanna, S. Garg, 2019, Journal of clinical gastroenterology.

Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection

D. Pardi, S. Khanna, Clayton M. Spiceland, 2016, Journal of clinical gastroenterology.

Fecal microbiota transplantation for gastrointestinal disorders

D. Pardi, S. Khanna, Thomas M Malikowski, 2017, Current opinion in gastroenterology.

Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study

D. Pardi, S. Khanna, R. Theiler, 2020, Therapeutic advances in gastroenterology.

Open‐label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

D. Rubin, S. Hanauer, J. Leighton, 2009, Inflammatory bowel diseases.

Optimal acid suppression therapy in critically ill patients.

D. Pardi, 2000, Annals of internal medicine.

Influence of Malpractice History on the Practice of Screening and Surveillance for Barrett's Esophagus

L. McMahon, S. Saini, P. Schoenfeld, 2008, The American Journal of Gastroenterology.

Letter: safety of immune checkpoint inhibitors in patients with pre‐established microscopic colitis—a single‐centre experience

D. Pardi, S. Kane, Thomas W Fredrick, 2021, Alimentary pharmacology & therapeutics.

The fate of indefinite and low‐grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation

J. Talwalkar, T. Smyrk, E. Loftus, 2013, Alimentary pharmacology & therapeutics.

Acute major gastrointestinal hemorrhage in inflammatory bowel disease.

C. Gostout, W. Sandborn, E. Loftus, 1999, Gastrointestinal endoscopy.

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

A. Zinsmeister, W. Sandborn, E. Loftus, 2010, Inflammatory bowel diseases.

Inflammatory bowel disease in the elderly

D. Pardi, S. Hussain, P. E. Evans, 2007 .

Treatment of Inflammatory Bowel Disease in the Elderly

M. Camilleri, E. Loftus, D. Pardi, 2002, Drugs & aging.

Biologics: how far can they go in Crohn’s disease?

D. Pardi, K. Dunleavy, 2022, Gastroenterology report.

Use of Anti-Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease.

D. Pardi, R. Shivashankar, 2017, Gastroenterology clinics of North America.

A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy.

K. Papadakis, W. Harmsen, E. Loftus, 2020, Inflammatory bowel diseases.

Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease.

L. Melton, W. Sandborn, E. Loftus, 1999, Inflammatory Bowel Diseases.

Non-IBD colitides (eosinophilic, microscopic).

D. Pardi, E. Yen, 2012, Best practice & research. Clinical gastroenterology.

Miscellaneous colitides

D. Pardi, 2012, Current opinion in gastroenterology.

Symptomatic overlap between irritable bowel syndrome and microscopic colitis

M. Camilleri, W. Sandborn, E. Loftus, 2007 .

Lymphocytic Colitis: clinical features, treatment, and outcomes

W. Sandborn, E. Loftus, W. Tremaine, 2002, American Journal of Gastroenterology.

Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease.

L. Melton, W. Sandborn, E. Loftus, 1999, Inflammatory bowel diseases.

Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn’s disease

J. Fletcher, T. Smyrk, J. Fidler, 2015, Abdominal Imaging.

Update on anti-tumor necrosis factor agents in Crohn disease.

Siddharth Singh, D. Pardi, 2014, Gastroenterology clinics of North America.

Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection

E. Loftus, D. Pardi, S. Khanna, 2021, Therapeutic advances in gastroenterology.

In Search of the (Clostridium difficile) Holy Grail.

D. Pardi, S. Khanna, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

IBD: Poor outcomes after Clostridium difficile infection in IBD

D. Pardi, S. Khanna, 2012, Nature Reviews Gastroenterology &Hepatology.

Symptomatic overlap between irritable bowel syndrome and microscopic colitis.

M. Camilleri, W. Sandborn, E. Loftus, 2011, Inflammatory bowel diseases.

Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

E. Loftus, D. Pardi, S. Khanna, 2018, Inflammatory bowel diseases.

Letter: clinical predictors of Clostridium difficile infection – advanced age and residential status are important factors for prediction and prevention – authors' reply

L. Baddour, D. Pardi, S. Khanna, 2015, Alimentary pharmacology & therapeutics.

Outcomes from Rectal Vancomycin Therapy in Patients With Clostridium difficile Infection

D. Pardi, S. Khanna, L. Estes, 2014, The American Journal of Gastroenterology.

Comparative Outcomes of Younger and Older Hospitalized Patients with Inflammatory Bowel Disease Treated with Corticosteroids

A. Zinsmeister, W. Harmsen, E. Loftus, 2013, Inflammatory bowel diseases.

New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation

T. Smyrk, W. Tremaine, D. Pardi, 2016, The American Journal of Gastroenterology.

Symptomatic Overlap Between Microscopic Colitis and Irritable Bowel Syndrome: A Prospective Study

W. Sandborn, E. Loftus, W. Tremaine, 2013, Inflammatory bowel diseases.

T1193 A Randomized, Double-Blind, Placebo-Controlled Trial of Budesonide for the Treatment of Active Lymphocytic Colitis

W. Sandborn, E. Loftus, W. Tremaine, 2009 .

Clostridium difficile: An update

D. Pardi, J. Gonenne, Jonathan Gonenne, 2004, Comprehensive therapy.

Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease.

R. Qin, W. Sandborn, E. Loftus, 2010, Archives of surgery.

Presence of immune deficiency increases the risk of hospitalization in patients with norovirus infection.

D. Pardi, S. Khanna, M. Espy, 2017, Diagnostic microbiology and infectious disease.

Age at onset of inflammatory bowel disease and the risk of surgery for non‐neoplastic bowel disease

A. Zinsmeister, W. Harmsen, W. Sandborn, 2007, Alimentary pharmacology & therapeutics.

Case report

T. Cotter, E. Loftus, W. Tremaine, 2017, Medicine.

Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea

Yava L Jones-Hall, Robin Patel, T. Smyrk, 2018, Science Translational Medicine.

Renal and Urologic Complications of Inflammatory Bowel Disease

W. Sandborn, W. Tremaine, D. Pardi, 1998, American Journal of Gastroenterology.

Re: Kreiss et al.: pneumatosis intestinalis complicating C. difficile pseudomembranous colitis

J. Leighton, D. Pardi, 2000, American Journal of Gastroenterology.

Hematological Monitoring in Patients Receiving Aminosalicylates

D. Pardi, 2000 .

Screening for Clostridium difficile colonization on admission to a hematopoietic stem cell transplant unit may reduce hospital‐acquired C difficile infection

D. Pardi, P. Kashyap, S. Khanna, 2017, American journal of infection control.

Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection

H. Fadel, D. Pardi, S. Khanna, 2021, Infection and drug resistance.

Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (D-IBS)

M. Camilleri, D. Burton, D. Pardi, 2000 .

Mayo clinic gastroenterology and hepatology board review

D. Pardi, J. Poterucha, S. Hauser, 2004 .

Management of the Elderly Patients with Inflammatory Bowel Disease: Practical Considerations

C. Surawicz, D. Pardi, S. Katz, 2013, Inflammatory bowel diseases.

Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

D. Pardi, S. Khanna, R. Tariq, 2020, Journal of clinical gastroenterology.

Pouchitis After Restorative Proctocolectomy

W. Sandborn, D. Pardi, 2010, Evidence-based Gastroenterology and Hepatology 4e.

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Siddharth Singh, W. Sandborn, D. Pardi, 2019, The Cochrane database of systematic reviews.

Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

J. Talwalkar, Siddharth Singh, E. Loftus, 2013, Inflammatory bowel diseases.

S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections

W. Shannon, D. Pardi, S. Khanna, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial

J. Wortman, M. Henn, R. Pomerantz, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis

D. Pardi, S. Khanna, R. Tariq, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High risk of post‐infectious irritable bowel syndrome in patients with Clostridium difficile infection

Robin Patel, M. Grover, D. Pardi, 2016, Alimentary pharmacology & therapeutics.

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.

M. Henn, C. Kelly, M. Vulić, 2016, The Journal of infectious diseases.

Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.

E. Dubberke, D. Pardi, M. Ramesh, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COLLAGENOUS COLITIS IS ASSOCIATED WITH HLA SIGNATURE AND SHARES GENETIC RISKS WITH OTHER IMMUNE-MEDIATED DISEASES.

Judy H. Cho, E. Stahl, T. Raj, 2020, Gastroenterology.

Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression

A. Zinsmeister, T. Cotter, L. Baddour, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center.

K. Papadakis, E. Loftus, W. Tremaine, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Budesonide in the treatment of inflammatory bowel disease: The first year of experience in clinical practice

W. Sandborn, E. Loftus, W. Tremaine, 2006, Inflammatory bowel diseases.

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.

W. Kremers, K. Lindor, E. Loftus, 2001, Gastroenterology.

High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

K. Lindor, K. Kowdley, V. Luketic, 2011, The American Journal of Gastroenterology.

Factors Predicting Initial Career Choices in Gastroenterology Fellows

G. Gores, D. Pardi, A. Oxentenko, 2007, Journal of clinical gastroenterology.

Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis

Siddharth Singh, Arjun Gupta, D. Pardi, 2017, JAMA internal medicine.

CASE REPORT: Use of Montelukast as Steroid-Sparing Agent for Recurrent Eosinophilic Gastroenteritis

D. Schwartz, J. Murray, D. Pardi, 2001, Digestive Diseases and Sciences.

Clostridium difficile infection in patients with chronic kidney disease.

L. Baddour, Q. Qian, D. Pardi, 2012, Mayo Clinic proceedings.

Iliac arteriovenous fistula with renal insufficiency, ascites, hepatomegaly, and abnormal liver test results.

D. Pardi, M. Chiorean, R. Morford, 2001, Mayo Clinic proceedings.

Assessment of appropriateness of indications for CT enterography in younger patients

C. McCollough, J. Fletcher, J. Huprich, 2010, Inflammatory bowel diseases.

HEPATITIS-ASSOCIATED APLASTIC ANEMIA AND ACUTE PARVOVIRUS B19 INFECTION: A REPORT OF TWO CASES AND A REVIEW OF THE LITERATURE

Y. Romero, D. Pardi, D. Douglas, 1998, American Journal of Gastroenterology.

Chronic Diarrhea: Diagnosis and Management.

D. Pardi, L. Schiller, J. Sellin, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

What Is the Role of Diet in the Pathogenesis of Chronic Diarrhea ? Recommendations 6

D. Pardi, L. Schiller, J. Sellin, 2016 .

Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.

Zhen Wang, M. Murad, Siddharth Singh, 2015, Gastroenterology.

Comparative Ef fi cacy of Pharmacologic Interventions in Preventing Relapse of Crohn ’ s Disease After Surgery

Zhen Wang, M. Murad, Siddharth Singh, 2014 .

Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease.

Joel G Fletcher, David M Hough, Jayawant N Mandrekar, 2009, AJR. American journal of roentgenology.

American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis.

W. Tremaine, D. Pardi, A. Carrasco-Labra, 2016, Gastroenterology.

Predicting microscopic colitis before colon biopsies: a look into the crystal ball?

D. Pardi, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Extended-release Multimatrix Budesonide for Microscopic Colitis.

T. Cotter, E. Loftus, W. Tremaine, 2017, Inflammatory bowel diseases.

Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.

Samir A. Shah, M. Silverberg, S. Vermeire, 2021, The lancet. Gastroenterology & hepatology.

Limited Clinical Utility of a Self-Administered Tool for Predicting Medication Adherence Behavior in IBD

A. Zinsmeister, W. Harmsen, W. Sandborn, 2011 .

Management of Acute and Chronic Pouchitis

D. Pardi, L. Raffals, June Tome, 2022, Diseases of the colon and rectum.

Cytomegalovirus Infection of the Ileoanal Pouch: Clinical Characteristics and Outcomes

K. Papadakis, T. Smyrk, E. Loftus, 2013, Inflammatory bowel diseases.

Systematic review: the management of pouchitis

W. Sandborn, D. Pardi, 2006, Alimentary pharmacology & therapeutics.

CMV Infection of the Pouch : Clinical Characteristics , Diagnosis , Treatment , and Outcome

K. Papadakis, T. Smyrk, E. Loftus, 2022 .

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial

Joel G Fletcher, James E Huprich, Jeff L Fidler, 2008, Gastrointestinal endoscopy.

Acute major lower GI Hemorrhage in inflammatory bowel disease

C. Gostout, W. Sandborn, E. Loftus, 1997 .

The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease

L. Baddour, E. Loftus, Arjun Gupta, 2017, Scandinavian journal of gastroenterology.

An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials

M. Silverberg, R. Pai, P. Gionchetti, 2021, Alimentary pharmacology & therapeutics.

Clostridium difficile infection after restorative proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis

D. Pardi, S. Khanna, E. Dozois, 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis

D. Pardi, B. Shen, 2008, Endoscopy.

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis.

M. Silverberg, L. Stitt, S. Travis, 2018, Gastrointestinal endoscopy.

Clinical Features and Outcomes of Cytomegalovirus Colitis or Pouchitis in Patients with Inflammatory Bowel Disease: 857

W. Sandborn, E. Loftus, W. Tremaine, 2005 .

Acute Kidney Injury is an Independent Marker of Severity in Clostridium difficile Infection: A Nationwide Survey

L. Baddour, D. Pardi, S. Khanna, 2013, Journal of clinical gastroenterology.

The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study.

A. Zinsmeister, W. Harmsen, T. Smyrk, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Outcomes of Patients With Microscopic Colitis Treated With Corticosteroids: A Population-Based Study

T. Smyrk, W. Sandborn, E. Loftus, 2013, The American Journal of Gastroenterology.

Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine.

W. Sandborn, E. Loftus, W. Tremaine, 2001, Gastroenterology.

Microscopic colitis, checkpoint inhibitor colitis, and other miscellaneous inflammatory and structural disorders of the colon

D. Pardi, E. Yen, Edward V Loftus, 2022, Yamada's Textbook of Gastroenterology.

Current Approach to the Evaluation and Management of Microscopic Colitis

T. Cotter, D. Pardi, 2017, Current Gastroenterology Reports.

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota

L. Melton, A. Zinsmeister, W. Harmsen, 2006, Gut.

Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study

Kristin E. Burke, Daniel D. Penrice, D. Pardi, 2021, Digestive Diseases and Sciences.

Immune modulator therapy for microscopic colitis in a case series of 73 patients

T. Cotter, E. Loftus, W. Tremaine, 2017, Alimentary pharmacology & therapeutics.

Validation of a Scoring System to Predict Microscopic Colitis in a Cohort of Patients With Chronic Diarrhea.

T. Cotter, D. Pardi, M. Binder, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Treatment outcomes in lymphocytic collitis

W. Sandborn, E. Loftus, W. Tremaine, 2001 .

Clostridium difficile infection: new insights into management.

D. Pardi, S. Khanna, 2012, Mayo Clinic proceedings.

Medication use and microscopic colitis: a multicentre retrospective cohort study

Nicole De Cuir, D. Pardi, S. Khanna, 2021, Alimentary pharmacology & therapeutics.

Inflammatory Bowel Disease of the Elderly: Frequently Asked Questions (FAQs)

D. Pardi, S. Katz, 2011, The American Journal of Gastroenterology.

Early measles virus infection is associated with the development of inflammatory bowel disease.

L. Melton, A. Zinsmeister, W. Harmsen, 2000 .

Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis.

D. Pardi, L. Beaugerie, 2009, Gastroenterology.

Tacrolimus Salvage in Anti–Tumor Necrosis Factor Antibody Treatment-Refractory Crohn’s Disease

D. Pardi, P. Kammer, D. Bruining, 2013, Inflammatory bowel diseases.

Diagnostic Ionizing Radiation Exposure in a Population-Based Cohort of Patients with Inflammatory Bowel Disease

B. Schueler, C. McCollough, J. Fletcher, 2008, The American Journal of Gastroenterology.

Report of the multisociety task force on GI training

G. Gores, L. Brandt, J. Kuemmerle, 2009, Hepatology.

Report of the Multisociety Task Force on GI Training

G. Gores, L. Brandt, J. Kuemmerle, 2009, American Journal of Gastroenterology.

Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients.

T. Smyrk, D. Pardi, S. Akram, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Report of the Multisociety Task Force on GI training.

G. Gores, L. Brandt, J. Kuemmerle, 2009, Gastrointestinal endoscopy.

Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience

A. Zinsmeister, W. Harmsen, W. Sandborn, 2012, Inflammatory bowel diseases.

Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysis.

David H. Johnson, Arjun Gupta, D. Pardi, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.

Siddhant Yadav, Sunanda V Kane, J. Talwalkar, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis

D. Pardi, S. Khanna, R. Tariq, 2020, Mayo Clinic Proceedings.

Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile infection

D. Pardi, S. Khanna, 2016, Expert review of gastroenterology & hepatology.

Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection

L. Baddour, Arjun Gupta, D. Pardi, 2016, Internal and Emergency Medicine.

Clostridium difficile infection: management strategies for a difficult disease

D. Pardi, S. Khanna, 2014, Therapeutic advances in gastroenterology.

The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

A. Zinsmeister, W. Harmsen, J. S. St. Sauver, 2012, The American Journal of Gastroenterology.

The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings

D. Pardi, S. Khanna, Darrell S Pardi, 2010, Expert review of gastroenterology & hepatology.

Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis.

D. Pardi, S. Khanna, A. Schuetz, 2019, Anaerobe.

Clinical factors associated with development of severe-complicated Clostridium difficile infection.

A. Zinsmeister, W. Harmsen, L. Baddour, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis

Siddharth Singh, Arjun Gupta, D. Pardi, 2018, Infection and drug resistance.

Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.

E. Loftus, J. DiBaise, D. Pardi, 2019, Inflammatory bowel diseases.

Clostridium difficile-associated diarrhea and colitis.

D. Pardi, T. Young‐Fadok, N. Zein, 2001, Mayo Clinic proceedings.

Non–Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease

E. Loftus, D. Pardi, S. Khanna, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

An Evaluation of Repeat Stool Testing for Clostridium difficile Infection by Polymerase Chain Reaction

Robin Patel, J. Rosenblatt, L. Baddour, 2012, Journal of clinical gastroenterology.

Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease

Siddharth Singh, L. Prokop, D. Pardi, 2021, Journal of clinical gastroenterology.

Extraintestinal Clostridium difficile infections: a single-center experience.

Robin Patel, L. Baddour, Arjun Gupta, 2014, Mayo Clinic proceedings.

Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.

L. Baddour, D. Pardi, S. Khanna, 2012, Mayo Clinic proceedings.

Update on Treatment of Clostridioides difficile Infection.

D. Pardi, S. Khanna, Janice M. Cho, 2020, Mayo Clinic proceedings.

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection

C. Kelly, E. Hohmann, David A. Lombardi, 2023, JAMA network open.

Gastric acid suppression and outcomes from clostridium difficile infection: a population-based study

D. Pardi, S. Khanna, P. Kammer, 2011, Gut.

Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

D. Pardi, S. Khanna, K. Mara, 2021, Gastroenterology.

Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis

D. Pardi, S. Khanna, R. Tariq, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Abnormal findings on abdominopelvic cross-sectional imaging in patients with microscopic colitis: a retrospective, multicenter study

A. Koop, W. Palmer, D. Pardi, 2021, Scandinavian journal of gastroenterology.

The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study from 2011-2019.

W. Harmsen, E. Loftus, W. Tremaine, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Microscopic Colitis: A Concise Review for Clinicians.

D. Pardi, A. Kamboj, June Tome, 2021, Mayo Clinic proceedings.

Microscopic Colitis, Collagenous and Lymphocytic

D. Pardi, A. Kamboj, 2018 .

Clinical predictors of recurrent Clostridium difficile infection in out‐patients

A. Zinsmeister, L. Baddour, D. Pardi, 2014, Alimentary pharmacology & therapeutics.

Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection

D. Pardi, S. Khanna, R. Tariq, 2021, Expert review of anti-infective therapy.

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement.

K. Papadakis, J. Fletcher, J. Fidler, 2018, Inflammatory bowel diseases.

The epidemiology of Clostridium difficile infection in children: a population-based study.

A. Zinsmeister, W. Harmsen, L. Baddour, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

413 Age is not Associated With Adverse Events From Biologic Therapy in Patients With Inflammatory Bowel Disease

A. Zinsmeister, W. Harmsen, W. Sandborn, 2010 .

Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single‐Institution Retrospective Case Series

M. Patnaik, D. Pardi, S. Khanna, 2017, Mayo Clinic proceedings.

Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice

D. Pardi, S. Khanna, P. Kammer, 2017, Mayo Clinic proceedings. Innovations, quality & outcomes.

Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes

R. Xavier, A. Ananthakrishnan, Darrick K. Li, 2016, Digestive Diseases and Sciences.

Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?

W. Sandborn, D. Pardi, William J. Sandborn, 2005, Gut.

Epidemiology, risk factors and management of cardiovascular diseases in IBD

I. Kullo, Siddharth Singh, E. Loftus, 2015, Nature Reviews Gastroenterology &Hepatology.

Comparative efficacy of biologic therapy in biologic-naïve patients with Crohn disease: a systematic review and network meta-analysis.

Zhen Wang, M. Murad, Siddharth Singh, 2014, Mayo Clinic proceedings.

Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases

E. Loftus, W. Tremaine, D. Pardi, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Benefit of Computed Tomography Enterography in Crohn's Disease: Effects on Patient Management and Physician Level of Confidence§†

J. Fletcher, J. Mandrekar, W. Harmsen, 2012, Inflammatory bowel diseases.

Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients With Inflammatory Bowel Disease

K. Papadakis, E. Loftus, S. Park, 2019, Crohn's & Colitis 360.

Melanosis coli in inflammatory bowel disease.

K. Batts, W. Tremaine, D. Pardi, 1998, Journal of clinical gastroenterology.

Chronic unexplained diarrhea: a logical and cost-effective approach to assessment

D. Pardi, Grace Dosanjh, 2016, Current opinion in gastroenterology.

"Community-acquired Clostridium difficile infection: an emerging entity".

D. Pardi, S. Khanna, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microscopic colitis is not associated with cholecystectomy or appendectomy

A. Zinsmeister, T. Smyrk, C. Schleck, 2006, Inflammatory bowel diseases.

Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic

D. Rubin, A. Khoruts, D. Pardi, 2021, Mayo Clinic Proceedings.

Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis

D. Pardi, S. Khanna, R. Tariq, 2021, Therapeutic advances in gastroenterology.

Response to 'Comments on the published systematic review and meta-analysis on the increasing antibiotic resistance in Clostridioides difficile' by Kouhsari et al.

D. Pardi, S. Khanna, A. Schuetz, 2020, Anaerobe.

Report of the AGA Institute Education and Training Committee Task Force on physician reentry.

D. Proctor, D. Pardi, A. Decross, 2010, Gastroenterology.

Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows

K. Obstein, J. Onken, D. Pardi, 2021, Hepatology.

Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows

K. Obstein, J. Onken, D. Pardi, 2021, The American journal of gastroenterology.

Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.

K. Obstein, J. Onken, D. Pardi, 2021, Gastroenterology.

Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.

K. Obstein, J. Onken, D. Pardi, 2021, Gastrointestinal endoscopy.

Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis

Siddharth Singh, D. Pardi, S. Khanna, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is early colonoscopy after admission for acute diverticular bleeding needed?

L. Melton, A. Zinsmeister, W. Harmsen, 2003, American Journal of Gastroenterology.

Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography

J. Fletcher, S. Khosla, T. Keaveny, 2014, The American Journal of Gastroenterology.

The Epidemiology of Clostridium dif fi cile Infection in Children : A Population-Based Study

A. Zinsmeister, W. Harmsen, L. Baddour, 2013 .

Outcomes in community‐acquired Clostridium difficile infection

L. Baddour, D. Pardi, S. Khanna, 2012, Alimentary pharmacology & therapeutics.

Observer variability in the histologic diagnosis of microscopic colitis

A. Zinsmeister, S. Sanderson, T. Smyrk, 2009, Inflammatory bowel diseases.

Editorial: additional evidence for drug‐induced microscopic colitis

D. Pardi, T. Cotter, 2016, Alimentary pharmacology & therapeutics.

Microscopic colitis.

D. Pardi, 2014, Clinics in Geriatric Medicine.

Validation of the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Its Correlation With Clinical Indices and Laboratory Measures of Disease Activity

A. Zinsmeister, W. Harmsen, W. Sandborn, 2011 .

Colorectal cancer screening perceptions and practices: Results from a national survey of gastroenterology, surgery and radiology trainees

R. Vierkant, D. Hough, T. Hartman, 2009, Journal of Cancer Education.

Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: Data from a national survey

R. Vierkant, J. Kolars, B. Levin, 2009, Journal of Cancer Education.

W1240 Adalimumab for Crohn's Disease in Clinical Practice At An Academic Medical Center: the First 118 Patients

A. Zinsmeister, W. Harmsen, W. Sandborn, 2008 .

S1211 Clinical Benefit of CT Enterography in Suspected or Established Crohn's Disease: Impact On Patient Management and Physician Level of Confidence

J. Fletcher, J. Mandrekar, W. Harmsen, 2008 .

Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection

D. Pardi, S. Khanna, P. Kammer, 2016, Journal of clinical gastroenterology.

Training in small-bowel capsule endoscopy: assessing and defining competency.

T. Baron, J. Murray, C. Gostout, 2013, Gastrointestinal endoscopy.

Reply to Khoruts and Sadowsky

D. Pardi, S. Khanna, R. Tariq, 2019, Clinical Infectious Diseases.

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

J. Faith, D. Pardi, S. Khanna, 2023, JAMA.

The natural history of histological changes in microscopic colitis

D. Pardi, S. Khanna, A. Kamboj, 2023, Therapeutic advances in gastroenterology.

After budesonide, what next for collagenous colitis?

D. Pardi, 2008, Gut.

Letter: the definition of budesonide dependence in microscopic colitis—authors’ reply

T. Cotter, E. Loftus, W. Tremaine, 2017, Alimentary pharmacology & therapeutics.

841 The Natural History of Microscopic Colitis Treated with Corticosteroids

S. Cha, T. Smyrk, W. Sandborn, 2008 .

Wireless capsule endoscopy appears to be superior to all current forms of radiological investigation of the small intestine in detecting the mucosal abnormalities of Crohn ’ s disease

D. Pardi, 2005 .

In reply—Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates

D. Pardi, S. Khanna, R. Tariq, 2021, Mayo Clinic Proceedings.

Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease

Sophie J. Weiss, R. Knight, Antonio Gonzalez, 2017, Microbiome.

Outcomes and Management of Patients with Failed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection

D. Pardi, S. Khanna, P. Kammer, 2017 .

Outcomes from Fecal Microbiota Transplantation in Adults with C. difficile Infection and Inflammatory Bowel Disease: 1688

E. Loftus, D. Pardi, P. Kashyap, 2013 .

The Match: five years later.

D. Proctor, D. Pardi, T. N. Jones, 2011, Gastroenterology.

Durability Of Response To Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence In Patients With Clostridioides difficile Infection.

D. Pardi, S. Khanna, K. Mara, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.

D. Pardi, S. Khanna, 2020, The American journal of gastroenterology.

Knowledge of Hepatocellular Carcinoma Screening Guidelines and Clinical Practices Among Gastroenterologists

J. Marrero, S. Saini, P. Schoenfeld, 2011, Digestive Diseases and Sciences.

Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection.

D. Pardi, S. Khanna, P. Tosh, 2023, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

The Association of Serologic Inflammatory Markers with Microscopic Colitis Disease Activity: 420

W. Sandborn, E. Loftus, W. Tremaine, 2011 .

Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease.

A. Koop, D. Pardi, S. Khanna, 2023, Journal of gastroenterology and hepatology.

Resolution rates in clinical trials for microbiota restoration for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis

D. Pardi, S. Khanna, R. Tariq, 2023, Therapeutic advances in gastroenterology.

109: AN 8-STRAIN, RATIONALLY DEFINED BACTERIAL CONSORTIUM, VE303, REDUCES THE RISK OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) RECURRENCE COMPARED WITH PLACEBO IN ADULTS AT HIGH RISK FOR RECURRENCE: RESULTS OF THE PHASE 2 CONSORTIUM STUDY

D. Pardi, S. Khanna, N. Erpelding, 2022, Gastroenterology.

Su1420 Ustekinumab Treatment for Crohn's Disease in Clinical Practice: Experience At a Tertiary Medical Center

K. Papadakis, W. Harmsen, E. Loftus, 2014 .

Should the National GI Fellowship Matching Program Be Restored?

D. Pardi, 2004, American Journal of Gastroenterology.

Outcomes in Patients with Recurrent Clostridium Difficile Infection Treated with Vancomycin Taper

A. Meehan, D. Pardi, S. Khanna, 2017 .

The Effect of Clostridium difficile Infection on Pregnancy and Neonatal Outcomes: An Observational Study

D. Pardi, S. Khanna, S. Saha, 2018, American Journal of Gastroenterology.

624 – Comparison of Two Open-Label Trials Demonstrates Similar 6-Month Outcomes for Rbx2660 and Rbx7455—Investigational Microbiota Restoration Therapeutics Administered by Enema Or Oral Capsules for Preventing Recurrent Clostridium Difficile Infections

E. Deych, D. Gerding, E. Dubberke, 2019, Gastroenterology.

Prevalence and Impact of Musculoskeletal Injury Among Endoscopists: A Controlled Study

M. Crowell, D. Pardi, S. Hansel, 2007 .

What do gastroenterology trainees want: recognition, remuneration or recreation?

J. Maple, D. Pardi, H. Aslanian, 2011, Irish journal of medical science.

T1027 What Do Gastroenterology Trainees Want: Recognition, Remuneration or Recreation?

J. Maple, D. Pardi, H. Aslanian, 2010 .

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era

D. Pardi, S. Khanna, 2020, The American journal of gastroenterology.

Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection A Systematic-review and Meta-analysis

M. Grover, D. Pardi, S. Khanna, 2021 .

Inflammatory Bowel Disease in the Elderly

D. Pardi, S. Hussain, 2010, Drugs & aging.

Report of the multisociety task force on GI training.

G. Gores, L. Brandt, J. Kuemmerle, 2009, Gastroenterology.

Mentorship Programs for Gastroenterology Program Directors: Is there an Unmet Need?

D. Pardi, A. Oxentenko, S. Norby, 2011, Journal of clinical gastroenterology.

119 Kinetics of Stool Polymerase Chain Reaction in Clostridioides difficile Infection and Its Utility in Predicting Recurrence

Robin Patel, D. Pardi, S. Khanna, 2019, American Journal of Gastroenterology.

621 Incidence and Outcomes From Clostridium difficile Infection in Hospitalized Adults With Inflammatory Bowel Disease

L. Baddour, E. Loftus, D. Pardi, 2012 .

Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis: A Systematic Review and Meta-analysis.

Jana G Hashash, D. Pardi, F. Farraye, 2023, Journal of clinical gastroenterology.

Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis

E. Loftus, Lizhi Zhang, D. Pardi, 2022, Crohn's & colitis 360.

Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection

Robin Patel, D. Knights, E. Montassier, 2016, Alimentary pharmacology & therapeutics.

Early infection with measles virus is associated with an increased risk of ulcerative colitis

A. Zinsmeister, W. Sandborn, E. Loftus, 1998 .

The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis

K. Papadakis, E. Loftus, S. Park, 2019, Journal of clinical medicine.

S934 The Use of Biologics in Patients with Refractory Microscopic Colitis: A Single Center Experience

D. Pardi, V. Chedid, Chansong Choi, 2021, American Journal of Gastroenterology.

Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial

L. A. Christensen, D. Pardi, J. Hansen, 2008, Gut.

Outcomes in community‐acquired Clostridium difficile infection

L. Baddour, D. Pardi, S. Khanna, 2012, Alimentary pharmacology & therapeutics.

Corrigendum: The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

A. Zinsmeister, W. Harmsen, D. Pardi, 2012, The American Journal of Gastroenterology.

Outcomes in children with Clostridium difficile infection: results from a nationwide survey

L. Baddour, Arjun Gupta, D. Pardi, 2016, Gastroenterology report.

Gastro 2013 APDW/WCOG Shanghai Working Party Report: Chronic diarrhea: Definition, classification, diagnosis

R. Spiller, G. Krejs, D. Pardi, 2014, Journal of gastroenterology and hepatology.

Review article: microscopic colitis – lymphocytic, collagenous and ‘mast cell’ colitis

D. Pardi, E. Yen, 2011, Alimentary pharmacology & therapeutics.

Assessment of appropriateness of indications for CT enterography in younger patients

C. McCollough, J. Fletcher, J. Huprich, 2010, Inflammatory bowel diseases.

Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study

D. Pardi, S. Khanna, R. Theiler, 2023, Therapeutic advances in gastroenterology.

Wireless capsule endoscopy and Crohn’s disease

P. Swain, W. Sandborn, D. Pardi, 2005, Gut.

Wireless capsule endoscopy appears to be superior to all current forms of radiological investigation of the small intestine in detecting the mucosal abnormalities of Crohn ’ s disease

D. Pardi, 2005 .

Diagnosis and Management of Microscopic Colitis

D. Pardi, 2017, The American Journal of Gastroenterology.

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial.

A. Zinsmeister, B. Petersen, J. Fletcher, 2008, Gastrointestinal endoscopy.

Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.

E. Dubberke, D. Pardi, M. Ramesh, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

T. V. Van Schooneveld, D. Gerding, D. Pardi, 2015, JAMA.

Mo1116 The Efficacy and Safety of Rifaximin vs. Vancomycin in the Treatment of Mild to Moderate C. difficile Infection: A Randomized Double-Blind Active Comparator Trial

H. Dupont, D. Pardi, E. Bortey, 2012 .

What's Hot in the Red Journal This Month

K. Lindor, V. Luketic, D. Pardi, 2011, The American Journal of Gastroenterology.

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

E. Loftus, D. Pardi, S. Khanna, 2022, Journal of Gastrointestinal Infections.

Observer variability in the histologic diagnosis of microscopic colitis

A. Zinsmeister, S. Sanderson, T. Smyrk, 2009, Inflammatory bowel diseases.

Composition, diversity and potential utility of intervention-naïve pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound

N. Chia, D. Pardi, P. Jeraldo, 2021, Gut.

S1096 Pre-Operative Infliximab Exposure and the Occurrence of Post-Operative Complications Following Proctocolectomy and Ileal Pouch-Anal Anastomosis (IPAA) for Ulcerative Colitis (UC)

A. Zinsmeister, W. Harmsen, W. Sandborn, 2009 .

Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

D. Pardi, P. E. Evans, 2007, MedGenMed : Medscape general medicine.